tiprankstipranks
D.A. Davidson Reaffirms Their Hold Rating on Medifast (MED)
Blurbs

D.A. Davidson Reaffirms Their Hold Rating on Medifast (MED)

D.A. Davidson analyst Linda Bolton Weiser maintained a Hold rating on Medifast (MEDResearch Report) today and set a price target of $93.00. The company’s shares closed last Friday at $107.06.

Bolton Weiser covers the Consumer Cyclical sector, focusing on stocks such as Funko, Inter Parfums, and Coty. According to TipRanks, Bolton Weiser has an average return of 4.3% and a 50.42% success rate on recommended stocks.

Currently, the analyst consensus on Medifast is a Hold with an average price target of $93.00.

See Insiders’ Hot Stocks on TipRanks >>

Based on Medifast’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $348.98 million and a net profit of $39.97 million. In comparison, last year the company earned a revenue of $417.6 million and had a net profit of $41.78 million

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its product lines include weight loss, weight management and healthy living meal replacements, snacks, hydration products, and vitamins. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.

Read More on MED:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles